• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Emerg Microbes Infect . SARS-CoV-2 reinfection and COVID-19 severity

tetano

Editor, Senior Moderator
Emerg Microbes Infect


. 2022 Mar 10;1-41.
doi: 10.1080/22221751.2022.2052358. Online ahead of print.
SARS-CoV-2 reinfection and COVID-19 severity


Nhu Ngoc Nguyen[SUP] 1 2 [/SUP], Linda Houhamdi[SUP] 1 2 [/SUP], Van Thuan Hoang[SUP] 1 3 [/SUP], Jeremy Delerce[SUP] 1 4 2 [/SUP], Léa Delorme[SUP] 1 2 [/SUP], Philippe Colson[SUP] 1 4 2 [/SUP], Philippe Brouqui[SUP] 1 4 2 [/SUP], Pierre-Edouard Fournier[SUP] 1 2 [/SUP], Didier Raoult[SUP] 1 4 2 [/SUP], Philippe Gautret[SUP] 1 2 [/SUP]



Affiliations

Abstract

Background: SARS-CoV-2 reinfection rate is low. The relative severity of the first and second episodes of infection remains poorly studied.
Objective: In this study, we aimed at assessing the frequency of SARS-CoV-2 reinfections and comparing the severity of the first and second episodes of infection.
Methods: We retrospectively included patients with SARS-CoV-2 positive RT-PCR at least 90 days after clinical recovery from a COVID-19 episode and with at least one negative RT-PCR after the first infection. Whole genome sequencing and variant-specific RT-PCR were performed and clinical symptoms and severity of infection were retrospectively documented from medical files.
Results: A total of 209 COVID-19 reinfected patients were identified, accounting for 0.4% of positive cases diagnosed from March 19, 2020 to August 24, 2021. Serology was performed in 64 patients, of whom 39 (60.1%) had antibodies against SARS-CoV-2 when sampled at the early stage of their second infection. Only seven patients (3.4%) were infected twice with the same variant. We observed no differences in clinical presentation, hospitalization rate and transfer to ICU when comparing the two episodes of infections.
Conclusion: Our results suggest that the severity of a second episode of COVID-19 is in the same range of that of the first infection, including patients with antibodies.

Keywords: COVID-19; SARS-CoV-2; coronavirus; reinfection; severity.
 
Back
Top Bottom